After the fall: improving osteoporosis treatment following hip fracture

B. W. Kuiper*, S. Graybill, J. M. Tate, N. Kaufman, D. Bersabe

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Summary: Osteoporotic hip fractures can be life changing and can increase mortality. Treatment of osteoporosis following hip fracture is often delayed. We began offering osteoporosis medication during hospitalization for hip fracture, dramatically increasing the number of patients meeting standard of care. Introduction: Osteoporotic hip fracture is a debilitating condition with major morbidity and mortality implications. Osteoporosis medication given within 90 days of hip fracture improves mortality and reduces risk of future fractures. The aim of this project was to improve rates of timely osteoporosis treatment following fragility hip fracture. Methods: This was a two-step intervention utilizing the Plan-Do-Study-Act cycle, beginning with resident-focused education in cycle 1. In cycle 2, we offered osteoporosis medication to inpatients for hip fracture with help from a new electronic order set. Results: Prior to this intervention, 32% of patients received osteoporosis medication within 90 days of fragility hip fracture; this improved to 81% after intervention. Conclusions: Resident education and an electronic order set dramatically improved the percentage of patients meeting standard of care with osteoporosis pharmacotherapy following fragility fracture.

Original languageEnglish
Pages (from-to)1295-1301
Number of pages7
JournalOsteoporosis International
Issue number6
StatePublished - 1 Jun 2018
Externally publishedYes


  • Denosumab
  • Fragility hip fracture
  • Zoledronate


Dive into the research topics of 'After the fall: improving osteoporosis treatment following hip fracture'. Together they form a unique fingerprint.

Cite this